Related Experiment Video
Updated: Apr 18, 2026

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
Non-recurrence of carbamazepine induced vitiligo after rechallenge with carbamazepine
Masoomeh Saeedloo1, Seyed Vahid Shariat2
1Mental Health Research Center and Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Objective:
Vitiligo is a rare side effect of carbamazepine whose exact mechanism is unknown. The aim of this report is to describe a single case of vitiligo induced by carbamazepine.
Methods:
The case was a patient with Bipolar I disorder whose medications were changed from valproate to carbamazepine and who developed vitiligo after a short while. We followed the case for about four years when he was rechallenged with carbamazepine.
Results:
When depigmentation occurred, we immediately discontinued carbamazepine after which the depigmented areas improved gradually. About three years later, he received carbamazepine again, but depigmentation did not recur.
Conclusion:
Carbamazepine-induced vitiligo is not an absolute contraindication for the prescription of carbamazepine if other choices fail to respond or are not tolerated. The case has implications for the mechanism of medication induced vitiligo.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Allergic Reactions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Hypersensitivity Reactions: Immune-Complex Reactions
Desensitization and Tachyphylaxis
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

